Skip to content

FF/UMEC/VI

DRUG11 trials

Sponsors

GlaxoSmithKline, Dr. Grace Parraga

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Phase 3

Phase 4

INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design
CompletedNCT03467425
GlaxoSmithKlinePulmonary Disease, Chronic Obstructive
Start: 2018-04-11End: 2019-10-10Updated: 2020-09-07
A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT03474081
GlaxoSmithKlinePulmonary Disease, Chronic Obstructive
Start: 2018-03-29End: 2019-07-17Updated: 2021-07-15
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT03478696
GlaxoSmithKlinePulmonary Disease, Chronic Obstructive
Start: 2018-06-25End: 2019-03-18Updated: 2020-10-28
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT03478683
GlaxoSmithKlinePulmonary Disease, Chronic Obstructive
Start: 2018-06-25End: 2019-03-14Updated: 2020-10-28
A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT04923347
GlaxoSmithKlinePulmonary Disease, Chronic Obstructive
Start: 2023-06-06End: 2024-03-14Updated: 2025-03-24
To Evaluate Real-World Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol (FF/UMEC/VI) in a Single Inhaler (Trelegy Ellipta) in Participants With Symptomatic COPD
CompletedNCT05535972
GlaxoSmithKlinePulmonary Disease, Chronic Obstructive
Start: 2022-10-14End: 2023-09-25Updated: 2025-12-11

Related Papers